Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 73

Results For "CHI"

5488 News Found

Bristol Myers Squibb & Anthropic redraw biopharma with Claude-powered enterprise AI
Digitisation | May 21, 2026

Bristol Myers Squibb & Anthropic redraw biopharma with Claude-powered enterprise AI

BMS is moving beyond conversational AI into what it describes as “agentic” systems


Lilly's retatrutide delivers 30% weight loss in Phase 3 TRIUMPH-1 trial
News | May 21, 2026

Lilly's retatrutide delivers 30% weight loss in Phase 3 TRIUMPH-1 trial

All three dose levels, 4 mg, 9 mg and 12 mg, successfully met the primary and key secondary endpoints in 80 weeks


Boston Scientific invests $1.5 billion in MiRus for TAVR expansion
Medical Device | May 20, 2026

Boston Scientific invests $1.5 billion in MiRus for TAVR expansion

Deal includes exclusive option to acquire MiRus’ SIEGEL TAVR system for an additional $3 billion upon milestone achievements


Sukino Continuum appoints Sheshadri Vasan as President
People | May 20, 2026

Sukino Continuum appoints Sheshadri Vasan as President

Sheshadri brings with him extensive leadership experience spanning healthcare, diagnostics, telecom, and consumer goods industries


Decoding teleophthalmology role in transforming last-mile eye care in India
Opinion | May 20, 2026

Decoding teleophthalmology role in transforming last-mile eye care in India

By leveraging digital screening and remote consultation, the medical community is moving beyond the confines of the clinic


Gleneagles hospital performs customised 3D-printed hip reconstruction surgery
Hospitals | May 20, 2026

Gleneagles hospital performs customised 3D-printed hip reconstruction surgery

A high-resolution CT scan with 0.5 mm slices was used to design a customised titanium implant tailored to the patient’s anatomy and bone loss pattern


Apothecon Pharma appoints Shyamakant Giri as Group CEO
People | May 20, 2026

Apothecon Pharma appoints Shyamakant Giri as Group CEO

In his new role, he will lead the growth strategy for the group’s operations, including Apothecon Pharmaceuticals in India and Navinta LLC in the United States


Regeneron signs $2.32 billion deal with Parabilis for Helicon conjugates
News | May 20, 2026

Regeneron signs $2.32 billion deal with Parabilis for Helicon conjugates

The multi-target collaboration combines Regeneron’s industry-leading antibody capabilities with Parabilis’ novel Helicon peptide platform


HVS Hospitals records highest advanced clip therapy procedures in western India
Hospitals | May 20, 2026

HVS Hospitals records highest advanced clip therapy procedures in western India

The therapy is suited for patients with severe valve leakage who face elevated surgical risk due to advanced age, frailty, or multiple medical complications